Antibiotic compounds
AssigneeZeneca Limited
InventorsMichael John Betts, Gareth Morse Davies, Michael Lingard Swain
Life of this patent
Estimating the term…
Loading patent…
AssigneeZeneca Limited
InventorsMichael John Betts, Gareth Morse Davies, Michael Lingard Swain
Estimating the term…
The present invention relates to carbapenems and provides a compound of the formula (I): 1 or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof wherein: R1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R2 is hydrogen or C1-4alkyl; R3 is hydrogen or C1-4alkyl; R4 and R5 are the same or different and are selected from hydrogen, halo, cyano, C1-4alkyl, nitro, hydroxy, carboxy, C1-4alkoxy, C1-4alkoxycarbonyl, aminosulphonyl, C1-4alkylaminosulphonyl, di-C1-4-alkylaminosulphonyl, carbamoyl, C1-4alkylcarbamoyl, di-C1-4-alkylcarbamoyl, trifluoromethyl, sulphonic acid, amino, C1-4alkylamino, di-C1-4alkylamino, C1-4alkanoylamino, C1-4alkanoyl(N—C1-4alkyl)amino, C1-4alkanesulphonamido and C1-4alkylS(O)n— wherein n is zero, one or two: with the proviso that there is no hydroxy or carboxy substituent in a position ortho to the link to —NR3—. Processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them.
A compound of the formula (I):
A method of treatment of an infection by administering an antibacterially effective amount of a compound of the formula (I) to a patient in need thereof.
Dependencies are inferred from the claim text.